Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1'-((5-(aminomethyl)-1-(4,4,4-trifluorobutyl)-1h-1,3-benzodiazol-2-yl)methyl)-6'-fluoro-1',2'-dihydrospiro(cyclopropane-1,3'-indole)-2'-one
2. Rv521
1. Rv521
2. Rv-521
3. Sisunatovir [usan]
4. 1903763-82-5
5. Ke63tto7wk
6. Rv521.hcl
7. 1'-[[5-(aminomethyl)-1-(4,4,4-trifluorobutyl)benzimidazol-2-yl]methyl]-6'-fluorospiro[cyclopropane-1,3'-indole]-2'-one
8. 1'-{[5-(aminomethyl)-1-(4,4,4-trifluorobutyl)-1h-benzimidazol-2-yl]methyl}-6'-fluorospiro[cyclopropane-1,3'-indol]-2'(1'h)-one
9. Spiro(cyclopropane-1,3'-(3h)indol)-2'(1'h)-one, 1'-((5-(aminomethyl)-1-(4,4,4-trifluorobutyl)-1h-benzimidazol-2-yl)methyl)-6'-fluoro-
10. Rv521 Free Base
11. Unii-ke63tto7wk
12. Sisunatovir [inn]
13. Sisunatovir [who-dd]
14. Chembl4297497
15. Schembl19470916
16. Sisunatovir (synonyms: Rv521)
17. Ex-a4653
18. Bdbm50572450
19. Rv 521
20. Who 11253
21. Hy-123475
22. Cs-0082715
23. 1'-((5-(aminomethyl)-1-(4,4,4-trifluorobutyl)-1h-benzimidazol-2-yl)methyl)-6'-fluorospiro(cyclopropane-1,3'-(3h)indol)-2'(1'h)-one
24. 1'-((5-(aminomethyl)-1-(4,4,4-trifluorobutyl)-1h-benzo[d]imidazol-2-yl)methyl)-6'-fluorospiro[cyclopropane-1,3'-indolin]-2'-one
25. Wva
| Molecular Weight | 446.4 g/mol |
|---|---|
| Molecular Formula | C23H22F4N4O |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 446.17297399 g/mol |
| Monoisotopic Mass | 446.17297399 g/mol |
| Topological Polar Surface Area | 64.2 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 715 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Sisunatovir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sisunatovir, including repackagers and relabelers. The FDA regulates Sisunatovir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sisunatovir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sisunatovir supplier is an individual or a company that provides Sisunatovir active pharmaceutical ingredient (API) or Sisunatovir finished formulations upon request. The Sisunatovir suppliers may include Sisunatovir API manufacturers, exporters, distributors and traders.
Sisunatovir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sisunatovir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sisunatovir GMP manufacturer or Sisunatovir GMP API supplier for your needs.
A Sisunatovir CoA (Certificate of Analysis) is a formal document that attests to Sisunatovir's compliance with Sisunatovir specifications and serves as a tool for batch-level quality control.
Sisunatovir CoA mostly includes findings from lab analyses of a specific batch. For each Sisunatovir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sisunatovir may be tested according to a variety of international standards, such as European Pharmacopoeia (Sisunatovir EP), Sisunatovir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sisunatovir USP).
LOOKING FOR A SUPPLIER?
